BCM
RGNX icon

Burrage Capital Management’s Regenxbio RGNX Stock Holding History

Burrage Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-116,405
Closed -$3.2M – 29
2020
Q3 		$3.2M Buy
116,405
+1,405
+1% +$45.8K 2.53% 17
2020
Q2 		$4.24M Hold
115,000
– – 2.96% 17
2020
Q1 		$3.54M Buy
+115,000
New +$4.79M 3.48% 12

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Korea Investment Corp
Korea Investment Corp Seoul, South Korea $48.3B AUM 31.57% 1-Year Est. Return

Burrage Capital Management's RGNX Position: Q4 2020 in Review

Burrage Capital Management sold out of Regenxbio (RGNX) in Q4 2020, closing a stake of 116,405 shares — an estimated $3.2M sold.

Burrage Capital Management first reported a position in RGNX in Q1 2020 and held it in 3 quarters. The position peaked at $4.24M in Q2 2020. 187 funds tracked by Wall St. Rank hold RGNX as of Q4 2020.

  • Burrage Capital Management reported no remaining Regenxbio position as of Q4 2020 after selling out during the quarter.
  • Burrage Capital Management sold 116,405 Regenxbio shares in Q4 2020, an estimated $3.2M.
  • Burrage Capital Management first reported a position in Regenxbio in Q1 2020 and held it in 3 quarters.
  • Burrage Capital Management's Regenxbio position peaked at $4.24M in Q2 2020.
  • 187 funds tracked by Wall St. Rank held Regenxbio as of Q4 2020.

Based on Burrage Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.